drugset / Trial / NCT01037725

Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy Volunteers

NCT01037725

Phase 1 Completed 64 enrolled AstraZeneca Quintiles, Inc. · collab
RandomizedParallel-groupDouble-blindBasic science

Summary

The main purpose of this study is to assess the safety and tolerability of AZD5847 after receiving oral doses on a single day (Part A) or after receiving a single oral dose in two periods (Part B). For volunteers in Part B, the effect of food on the PK of AZD5847 will also be studied. Another purpose is to evaluate the pharmacokinetics (PK) of AZD5847 and its metabolites in blood and urine.

Timeline

Start
2009-12
Primary completion
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject POSIZOLID Small molecule Oral

Indications

No indication recorded.